T1	Participants 59 70	adolescents
T2	Participants 160 243	hypertensive adolescents requiring pharmacologic therapy for blood pressure control
T3	Participants 245 330	Twenty-four adolescents with persistent blood pressure elevation (greater than 95th%)
